omega-n-methylarginine has been researched along with captopril in 10 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (captopril) | Trials (captopril) | Recent Studies (post-2010) (captopril) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 10,320 | 1,514 | 890 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | captopril (IC50) |
---|---|---|---|
Leukotriene A-4 hydrolase | Homo sapiens (human) | 3.6 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.084 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0173 | |
Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | 3.3 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.1004 | |
Beta-lactamase | Pseudomonas aeruginosa | 5 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.011 | |
Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 3.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
de Graeff, PA; de Leeuw, MJ; Scholtens, E; van Gilst, WH; Wesseling, H | 1 |
Cachofeiro, V; Nasjletti, A; Sakakibara, T | 1 |
Bozhko, AP; Solodkov, AP | 1 |
Aikawa, J; Akatsuka, N; Fukazawa, M; Hara, K; Ishikawa, M; Moroi, M; Namiki, A; Yamaguchi, T | 1 |
Craven, PA; DeRubertis, FR; Felder, J; Phillips, S; Studer, RK | 1 |
MacCarthy, PA; Shah, AM | 1 |
Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
Brouwers, S; Dupont, AG; Massie, A; Smolders, I | 1 |
1 trial(s) available for omega-n-methylarginine and captopril
Article | Year |
---|---|
Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Bradykinin; Captopril; Coronary Circulation; Cysteine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Nitro Compounds; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Vasodilator Agents | 1991 |
9 other study(ies) available for omega-n-methylarginine and captopril
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Captopril; Hypertension; Imidazoles; Kinins; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1992 |
[Effect of endogenous metabolites on autoregulation and dilational reserve of coronary vessels].
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Captopril; Coronary Circulation; Coronary Vessels; Eicosanoids; Female; In Vitro Techniques; Indomethacin; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Vasodilation; Verapamil | 1993 |
Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Aspirin; Captopril; Dinoprost; Dipeptides; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Femoral Artery; In Vitro Techniques; Indans; Isometric Contraction; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; omega-N-Methylarginine; Oxyhemoglobins; Superoxide Dismutase | 1994 |
Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells.
Topics: Animals; Captopril; Cattle; Cells, Cultured; Coculture Techniques; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Glomerular Mesangium; Glucose; Indoles; Maleimides; Nitric Oxide; omega-N-Methylarginine; Osmolar Concentration; Penicillamine; Proline; Protein Kinase C; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Transforming Growth Factor beta; Tritium | 1997 |
Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Endothelium, Vascular; Guinea Pigs; Hypertrophy, Left Ventricular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vasodilator Agents | 2000 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fenoldopam; Imidazoles; Indomethacin; Kidney; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes; Vasodilation; Vasodilator Agents | 2013 |